Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
S. Sridhar, Arnel M. Joaquin, M. Bonaparte, Agustin Bueso +42 more

